Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 14,769 | 8,925 | N/A |
| TOTAL | $15,024 | $8,966 | $N/A |
| Non-Current Assets | |||
| PPE Net | 793 | 1,064 | N/A |
| Intangibles | 22 | 0 | 0 |
| Other Non-Current Assets | 1,471 | 0 | 0 |
| TOTAL | $2,286 | $1,064 | $N/A |
| Total Assets | $17,310 | $10,030 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 461 | 601 | 0 |
| Accrued Expenses | 1,788 | 711 | N/A |
| TOTAL | $2,249 | $1,312 | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $2,249 | $1,312 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 8 | 8 | N/A |
| Retained earnings | -151,752 | -56,278 | N/A |
| Other shareholders' equity | 161,787 | 64,026 | 0 |
| TOTAL | $15,061 | $8,718 | $N/A |
| Total Liabilities And Equity | $17,310 | $10,030 | $0 |